These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9128811)

  • 21. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency: a prospective cohort study.
    Pabinger I; Kyrle PA; Heistinger M; Eichinger S; Wittmann E; Lechner K
    Thromb Haemost; 1994 Apr; 71(4):441-5. PubMed ID: 8052960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age-specific incidence rates of venous thromboembolism among heterozygous carriers of factor V Leiden mutation.
    Ridker PM; Glynn RJ; Miletich JP; Goldhaber SZ; Stampfer MJ; Hennekens CH
    Ann Intern Med; 1997 Apr; 126(7):528-31. PubMed ID: 9092318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resistance to activated protein C as a basis for venous thrombosis.
    Svensson PJ; Dahlbäck B
    N Engl J Med; 1994 Feb; 330(8):517-22. PubMed ID: 8302317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal thrombo-embolism: risk factors, clinical features and outcome.
    Demirel N; Aydin M; Zenciroglu A; Bas AY; Yarali N; Okumus N; Cinar G; Ipek MS
    Ann Trop Paediatr; 2009 Dec; 29(4):271-9. PubMed ID: 19941750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resistance to activated protein C: a common inherited cause of venous thrombosis.
    Gillespie DL; Carrington LR; Griffin JH; Alving BM
    Ann Vasc Surg; 1996 Mar; 10(2):174-7. PubMed ID: 8733870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism.
    Nowak-Göttl U; Auberger K; Göbel U; Kreuz W; Schneppenheim R; Vielhaber H; Zenz W; Zieger B
    Eur J Pediatr; 1996 Nov; 155(11):921-7. PubMed ID: 8911889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombosis in the young: epidemiology and risk factors. A focus on venous thrombosis.
    Rosendaal FR
    Thromb Haemost; 1997 Jul; 78(1):1-6. PubMed ID: 9198119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis.
    Bertina RM; Reitsma PH; Rosendaal FR; Vandenbroucke JP
    Thromb Haemost; 1995 Jul; 74(1):449-53. PubMed ID: 8578504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden).
    Simioni P; Prandoni P; Lensing AW; Scudeller A; Sardella C; Prins MH; Villalta S; Dazzi F; Girolami A
    N Engl J Med; 1997 Feb; 336(6):399-403. PubMed ID: 9010145
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inherited resistance to activated protein C caused by presence of the FV:Q506 allele as a basis of venous thrombosis.
    Dahlbäck B; Zöller B; Hillarp A
    Haemostasis; 1996 Oct; 26 Suppl 4():301-14. PubMed ID: 8979136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to activate protein C, the Arg506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons.
    Dahlbäck B
    Thromb Haemost; 1995 May; 73(5):739-42. PubMed ID: 7482395
    [No Abstract]   [Full Text] [Related]  

  • 33. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance to activated protein C disclosed by postphlebitic disease. Two cases].
    Foueré S; Lestang P; Cosnes A; Gouault-Heilmann M; Revuz J
    Ann Dermatol Venereol; 1996; 123(1):24-5. PubMed ID: 8734112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect.
    Allaart CF; Poort SR; Rosendaal FR; Reitsma PH; Bertina RM; Briët E
    Lancet; 1993 Jan; 341(8838):134-8. PubMed ID: 8093743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous thrombosis in older people: prevalence of the factor V gene mutation Q506.
    André E; Siguret V; Alhenc-Gelas M; Saint-Jean O; Gaussem P
    J Am Geriatr Soc; 1998 Dec; 46(12):1545-9. PubMed ID: 9848816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of fibrinolysis and prothrombotic risk factors in neonates, infants and children with and without thromboembolism and underlying cardiac disease. a prospective study.
    Nowak-Göttl U; Kotthoff S; Hagemeyer E; Junker R; Kehl HG; Vielhaber H; Kececioglu D
    Thromb Res; 2001 Jul; 103(2):93-101. PubMed ID: 11457466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of genetic prothrombotic risk factors in childhood caval vein thrombosis.
    Münchow N; Kosch A; Schobess R; Junker R; Auberger K; Nowak-Göttl U
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S109-12. PubMed ID: 10650847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.